Systematic Review
Accepted on 07 Jan 2025
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
in Genitourinary Oncology